Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100154039> ?p ?o ?g. }
- W3100154039 abstract "Outbreak of Coronavirus Disease 2019 (COVID-19) has become a great challenge for scientific community globally. Virus enters cell through spike glycoprotein fusion with ACE2 (Angiotensin-Converting Enzyme 2) human receptor. Hence, spike glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a potential target for diagnostics, vaccines, and antibodies. Also, virus entry can be prevented by blocking ACE2 thus, ACE2 can be considered potential target for therapeutics. As being highly specific, safe and efficacious, peptides hold their place in therapeutics. In present study, we retrieved sequence of 70 peptides from Antiviral Peptide Database (AVPdb), modelled them using 3D structure predicting web tool and docked them with receptor binding domain (RBD) of spike protein and human host receptor ACE2 using peptide-protein docking. It was observed that peptides have more affinity towards ACE2 in comparison with spike RBD. Interestingly it was noticed that most of the peptides bind to RBM (residue binding motif) which is responsible for ACE2 binding at the interface of RBD while, for ACE2, peptides prefer to bind the core cavity rather than RBD binding interface. To further investigate how peptides at the interface of RBD or ACE2 alter the binding between RBD and ACE2, protein-protein docking of RBD and ACE2 with and without peptides was performed. Peptides, AVP0671 at RBD and AVP1244 at ACE2 interfaces significantly reduce the binding affinity and change the orientation of RBD and ACE2 binding. This finding suggests that peptides can be used as a drug to inhibit virus entry in cells to stop COVID-19 pandemic in the future after experimental evidences." @default.
- W3100154039 created "2020-11-23" @default.
- W3100154039 creator A5005223381 @default.
- W3100154039 creator A5020086344 @default.
- W3100154039 creator A5027375702 @default.
- W3100154039 creator A5028532470 @default.
- W3100154039 creator A5045610564 @default.
- W3100154039 creator A5061602094 @default.
- W3100154039 date "2020-11-09" @default.
- W3100154039 modified "2023-10-12" @default.
- W3100154039 title "Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2" @default.
- W3100154039 cites W1502426240 @default.
- W3100154039 cites W1965531501 @default.
- W3100154039 cites W1988620524 @default.
- W3100154039 cites W2000040025 @default.
- W3100154039 cites W2006785079 @default.
- W3100154039 cites W2028117310 @default.
- W3100154039 cites W2039389449 @default.
- W3100154039 cites W2044139515 @default.
- W3100154039 cites W2047544230 @default.
- W3100154039 cites W2069919158 @default.
- W3100154039 cites W2094942715 @default.
- W3100154039 cites W2095807050 @default.
- W3100154039 cites W2131275757 @default.
- W3100154039 cites W2132465034 @default.
- W3100154039 cites W2135634425 @default.
- W3100154039 cites W2167384912 @default.
- W3100154039 cites W2344689512 @default.
- W3100154039 cites W2954483845 @default.
- W3100154039 cites W3002108456 @default.
- W3100154039 cites W3006973065 @default.
- W3100154039 cites W3007643904 @default.
- W3100154039 cites W3008142620 @default.
- W3100154039 cites W3010441732 @default.
- W3100154039 cites W3011072970 @default.
- W3100154039 cites W3012296792 @default.
- W3100154039 cites W3012352458 @default.
- W3100154039 cites W3012764845 @default.
- W3100154039 cites W3013855790 @default.
- W3100154039 cites W3014067025 @default.
- W3100154039 cites W3014735311 @default.
- W3100154039 cites W3015313862 @default.
- W3100154039 cites W3015438624 @default.
- W3100154039 cites W3017291089 @default.
- W3100154039 cites W3018056400 @default.
- W3100154039 cites W3021100201 @default.
- W3100154039 cites W3021917713 @default.
- W3100154039 cites W3025110670 @default.
- W3100154039 cites W3030373252 @default.
- W3100154039 cites W3032202303 @default.
- W3100154039 cites W3032777307 @default.
- W3100154039 cites W3036090423 @default.
- W3100154039 cites W3037021404 @default.
- W3100154039 cites W3038931692 @default.
- W3100154039 cites W3080440589 @default.
- W3100154039 cites W3104554419 @default.
- W3100154039 cites W3116319748 @default.
- W3100154039 doi "https://doi.org/10.1007/s40203-020-00055-w" @default.
- W3100154039 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7649901" @default.
- W3100154039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33184600" @default.
- W3100154039 hasPublicationYear "2020" @default.
- W3100154039 type Work @default.
- W3100154039 sameAs 3100154039 @default.
- W3100154039 citedByCount "19" @default.
- W3100154039 countsByYear W31001540392021 @default.
- W3100154039 countsByYear W31001540392022 @default.
- W3100154039 countsByYear W31001540392023 @default.
- W3100154039 crossrefType "journal-article" @default.
- W3100154039 hasAuthorship W3100154039A5005223381 @default.
- W3100154039 hasAuthorship W3100154039A5020086344 @default.
- W3100154039 hasAuthorship W3100154039A5027375702 @default.
- W3100154039 hasAuthorship W3100154039A5028532470 @default.
- W3100154039 hasAuthorship W3100154039A5045610564 @default.
- W3100154039 hasAuthorship W3100154039A5061602094 @default.
- W3100154039 hasBestOaLocation W31001540391 @default.
- W3100154039 hasConcept C107824862 @default.
- W3100154039 hasConcept C108625454 @default.
- W3100154039 hasConcept C140704245 @default.
- W3100154039 hasConcept C142724271 @default.
- W3100154039 hasConcept C159047783 @default.
- W3100154039 hasConcept C159110408 @default.
- W3100154039 hasConcept C170493617 @default.
- W3100154039 hasConcept C185592680 @default.
- W3100154039 hasConcept C2522874641 @default.
- W3100154039 hasConcept C2775946041 @default.
- W3100154039 hasConcept C2777648638 @default.
- W3100154039 hasConcept C2779134260 @default.
- W3100154039 hasConcept C2779281246 @default.
- W3100154039 hasConcept C3008058167 @default.
- W3100154039 hasConcept C41685203 @default.
- W3100154039 hasConcept C51639874 @default.
- W3100154039 hasConcept C524204448 @default.
- W3100154039 hasConcept C55493867 @default.
- W3100154039 hasConcept C58475186 @default.
- W3100154039 hasConcept C71924100 @default.
- W3100154039 hasConcept C86803240 @default.
- W3100154039 hasConceptScore W3100154039C107824862 @default.
- W3100154039 hasConceptScore W3100154039C108625454 @default.
- W3100154039 hasConceptScore W3100154039C140704245 @default.
- W3100154039 hasConceptScore W3100154039C142724271 @default.